We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Sector Composition

Rank Sector Weight
1 Technology 26.99%
2 Healthcare 10.86%
3 Consumer Discretionary 10.71%
4 Financials 8.62%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DSGX icon
2451
Descartes Systems
DSGX
$6.62B
$114K ﹤0.01%
1,787
-2,254
-56% -$153K
HNI icon
2452
HNI Corp
HNI
$3.56B
$114K ﹤0.01%
4,312
+2,498
+138% +$82.9K
JAMF
2453
DELISTED
Jamf
JAMF
$114K ﹤0.01%
5,138
+4,531
+746% +$112K
JELD icon
2454
JELD-WEN Holding
JELD
$170M
$114K ﹤0.01%
13,020
+10,350
+388% +$136K
PFBC icon
2455
Preferred Bank
PFBC
$1.28B
$114K ﹤0.01%
1,741
+418
+32% +$29.2K
PPC icon
2456
Pilgrim's Pride
PPC
$6.57B
$114K ﹤0.01%
4,965
+1,685
+51% +$48.7K
UE icon
2457
Urban Edge Properties
UE
$2.78B
$114K ﹤0.01%
8,574
+3,426
+67% +$53.4K
XERS icon
2458
Xeris Biopharma Holdings
XERS
$1.52B
$114K ﹤0.01%
72,857
+40,913
+128% +$67.7K
EMBJ
2459
Embraer S.A. ADS
EMBJ
$13.2B
$113K ﹤0.01%
13,126
+9,562
+268% +$94.8K
GH icon
2460
Guardant Health
GH
$21.4B
$113K ﹤0.01%
2,098
-765
-27% -$39.3K
HTZ icon
2461
Hertz
HTZ
$838M
$113K ﹤0.01%
6,938
-30,181
-81% -$566K
PLRX icon
2462
Pliant Therapeutics
PLRX
$66.9M
$113K ﹤0.01%
5,412
+2,289
+73% +$43.8K
RPTX
2463
DELISTED
Repare Therapeutics
RPTX
$113K ﹤0.01%
+9,335
New +$120K
SMP icon
2464
Standard Motor Products
SMP
$870M
$113K ﹤0.01%
3,467
+1,848
+114% +$73.6K
VRT icon
2465
Vertiv
VRT
$111B
$113K ﹤0.01%
11,600
-24,225
-68% -$272K
TEN
2466
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$113K ﹤0.01%
6,495
+3,417
+111% +$64.2K
RPRX icon
2467
Royalty Pharma
RPRX
$26.1B
$112K ﹤0.01%
2,780
-3,465
-55% -$148K
TLRY icon
2468
Tilray
TLRY
$640M
$112K ﹤0.01%
4,048
-3,332
-45% -$117K
WSR
2469
DELISTED
Whitestone REIT
WSR
$112K ﹤0.01%
13,191
+9,972
+310% +$102K
XLV icon
2470
State Street Health Care Select Sector SPDR ETF
XLV
$44B
$112K ﹤0.01%
925
-19,573
-95% -$2.52M
AGI icon
2471
Alamos Gold
AGI
$13.8B
$111K ﹤0.01%
14,847
+444
+3% +$3.29K
EXFY icon
2472
Expensify
EXFY
$202M
$111K ﹤0.01%
7,420
+7,340
+9,175% +$137K
GABC icon
2473
German American Bancorp
GABC
$1.92B
$111K ﹤0.01%
3,108
+2,105
+210% +$77.7K
GTN icon
2474
Gray Television
GTN
$520M
$111K ﹤0.01%
7,753
+5,178
+201% +$95K
HTLD icon
2475
Heartland Express
HTLD
$979M
$111K ﹤0.01%
7,737
+5,740
+287% +$86.2K

Similar funds

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.